Blood Glucose Levels in Children During Anesthesia
Blood Glucose Levels in Children During Anesthesia: Incidence of Hypoglycemia During Anesthesia Induction and Its Relationship to Preoperative Fasting
This cross-sectional study aims to investigate blood glucose levels in children during general anesthesia and explore the incidence of hypoglycemia after anesthesia induction in relation to preoperative fasting.
Blood glucose will be measured following anesthesia induction and prior to discontinuing the administration of the anesthetic agent.
Study Overview
Detailed Description
This cross-sectional study aims to investigate blood glucose levels in children < 18 years during general anesthesia, and explore the incidence of hypoglycemia after anesthesia induction in relation to preoperative fasting.
The purpose is to evaluate whether guidelines for shortening the preoperative fasting period of children at our hospital have resulted in a shorter fasting duration and prevalence of low blood glucose levels during anesthesia induction. Also to shed light on blood glucose levels during general anesthesia and its correlation with intravenous fluid management and administration of steroidal anti-emetics.
Blood glucose sampling will be obtained and measured following anesthesia induction and prior to discontinuing the anesthetic agent. If general anesthesia lasts longer than one hour, additional blood glucose analysis will be conducted one hour after the first measurement.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Reykjavik, Iceland, 101
- Anesthesia Department Landspitali UH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Children under 18 years of age who undergo intervention under general anesthesia. The parent or guardian understands and speaks Icelandic.
Exclusion Criteria:
Coexisting disease or treatment that may affect fasting blood glucose level; Preoperative intravenous fluid administration; Beta-blockers; Insulin and corticosteroids, endocrine disorders, acute pain, and emergency interventions.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum blood glucose level
Time Frame: Immediately/within five minutes after anesthesia induction and prior to discontinuing the anesthesia administration.
|
Blood glucose sampling and measured during general anesthesia
|
Immediately/within five minutes after anesthesia induction and prior to discontinuing the anesthesia administration.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Thorunn S Eliasdottir, PhD, Landspitali, the University Hospital of Iceland and University of Iceland
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 47/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.